These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 10092084

  • 1. Control of C3b and C5b deposition by CD46 (membrane cofactor protein) after alternative but not classical complement activation.
    Devaux P, Christiansen D, Fontaine M, Gerlier D.
    Eur J Immunol; 1999 Mar; 29(3):815-22. PubMed ID: 10092084
    [Abstract] [Full Text] [Related]

  • 2. Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells.
    Barilla-LaBarca ML, Liszewski MK, Lambris JD, Hourcade D, Atkinson JP.
    J Immunol; 2002 Jun 15; 168(12):6298-304. PubMed ID: 12055245
    [Abstract] [Full Text] [Related]

  • 3. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
    Christiansen D, Loveland B, Kyriakou P, Lanteri M, Rubinstein E, Gerlier D.
    Mol Immunol; 2000 Jun 15; 37(12-13):687-96. PubMed ID: 11275254
    [Abstract] [Full Text] [Related]

  • 4. The paramyxoviruses simian virus 5 and mumps virus recruit host cell CD46 to evade complement-mediated neutralization.
    Johnson JB, Grant K, Parks GD.
    J Virol; 2009 Aug 15; 83(15):7602-11. PubMed ID: 19457998
    [Abstract] [Full Text] [Related]

  • 5. Ligation of human CD46 with purified complement C3b or F(ab')(2) of monoclonal antibodies enhances isoform-specific interferon gamma-dependent nitric oxide production in macrophages.
    Hirano A, Kurita-Taniguchi M, Katayama Y, Matsumoto M, Wong TC, Seya T.
    J Biochem; 2002 Jul 15; 132(1):83-91. PubMed ID: 12097164
    [Abstract] [Full Text] [Related]

  • 6. Cooperation between decay-accelerating factor and membrane cofactor protein in protecting cells from autologous complement attack.
    Brodbeck WG, Mold C, Atkinson JP, Medof ME.
    J Immunol; 2000 Oct 01; 165(7):3999-4006. PubMed ID: 11034410
    [Abstract] [Full Text] [Related]

  • 7. Expression of a hybrid complement regulatory protein, membrane cofactor protein decay accelerating factor on Chinese hamster ovary. Comparison of its regulatory effect with those of decay accelerating factor and membrane cofactor protein.
    Iwata K, Seya T, Ariga H, Nagasawa S.
    J Immunol; 1994 Apr 01; 152(7):3436-44. PubMed ID: 7511647
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46.
    Iwata K, Seya T, Yanagi Y, Pesando JM, Johnson PM, Okabe M, Ueda S, Ariga H, Nagasawa S.
    J Biol Chem; 1995 Jun 23; 270(25):15148-52. PubMed ID: 7541036
    [Abstract] [Full Text] [Related]

  • 10. Coordinate functions of multiple complement regulating molecules, CD46, CD55, and CD59.
    Loveland BE, Szokolai K, Johnstone RW, McKenzie IF.
    Transplant Proc; 1994 Jun 23; 26(3):1070-1. PubMed ID: 7518104
    [No Abstract] [Full Text] [Related]

  • 11. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
    Seya T, Okada M, Matsumoto M, Hong KS, Kinoshita T, Atkinson JP.
    Mol Immunol; 1991 Oct 23; 28(10):1137-47. PubMed ID: 1833639
    [Abstract] [Full Text] [Related]

  • 12. The conversion of human complement component C5 into fragment C5b by the alternative-pathway C5 convertase.
    DiScipio RG.
    Biochem J; 1981 Dec 01; 199(3):497-504. PubMed ID: 6918218
    [Abstract] [Full Text] [Related]

  • 13. Cell surface activation of the alternative complement pathway by the fusion protein of measles virus.
    Devaux P, Christiansen D, Plumet S, Gerlier D.
    J Gen Virol; 2004 Jun 01; 85(Pt 6):1665-1673. PubMed ID: 15166451
    [Abstract] [Full Text] [Related]

  • 14. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 15. Membrane cofactor protein (CD46) protects cells predominantly from alternative complement pathway-mediated C3-fragment deposition and cytolysis.
    Kojima A, Iwata K, Seya T, Matsumoto M, Ariga H, Atkinson JP, Nagasawa S.
    J Immunol; 1993 Aug 01; 151(3):1519-27. PubMed ID: 8335944
    [Abstract] [Full Text] [Related]

  • 16. Complement regulatory molecules on human myelin and glial cells: differential expression affects the deposition of activated complement proteins.
    Koski CL, Estep AE, Sawant-Mane S, Shin ML, Highbarger L, Hansch GM.
    J Neurochem; 1996 Jan 01; 66(1):303-12. PubMed ID: 8522968
    [Abstract] [Full Text] [Related]

  • 17. Functional properties of membrane cofactor protein of complement.
    Seya T, Atkinson JP.
    Biochem J; 1989 Dec 01; 264(2):581-8. PubMed ID: 2481448
    [Abstract] [Full Text] [Related]

  • 18. Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera.
    Seya T, Hara T, Iwata K, Kuriyama S, Hasegawa T, Nagase Y, Miyagawa S, Matsumoto M, Hatanaka M, Atkinson JP.
    Int Immunol; 1995 May 01; 7(5):727-36. PubMed ID: 7547700
    [Abstract] [Full Text] [Related]

  • 19. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
    Fischer E, Kazatchkine MD, Mecarelli-Halbwachs L.
    Eur J Immunol; 1984 Dec 01; 14(12):1111-4. PubMed ID: 6240408
    [Abstract] [Full Text] [Related]

  • 20. Formation of high-affinity C5 convertases of the alternative pathway of complement.
    Rawal N, Pangburn M.
    J Immunol; 2001 Feb 15; 166(4):2635-42. PubMed ID: 11160326
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.